Naked DNA prevents soman intoxication

Biochemical and Biophysical Research Communications

Volumn 328, Issue 4, 2005, Pages 901-905

  Fu, Ai Ling ^a   Wang, Yu Xia ^a   Sun, Man Ji ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Naked DNA; Organophosphates; Paraoxonase; Soman

Indexed keywords

ARYLDIALKYLPHOSPHATASE; NAKED DNA; PLASMID DNA; RECOMBINANT ENZYME; RECOMBINANT HUMAN PARAOXONASE; SOMAN; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; INTERMETHOD COMPARISON; LETHAL DOSE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VEIN;

EID: 13744256453     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.194     Document Type: Article

References (14)

1. W.F. Li, C.E. Furlong, and L.G. Costa Paraoxonase protects against cholorpyrifos toxicity in mice Toxicol. Lett. 76 1995 219 226
2. B. Mackess, P.M. Durrington, and M.I. Mackness Human serum paraoxonase Gene Pharmacol. 31 1998 329 336
3. D.M. Shih, L. Gu, Y.R. Xia, M. Navab, W.F. Li, S. Hama, L.W. Castellani, C.E. Furlong, L.G. Costa, A.M. Fogelman, and A.J. Lusis Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 394 1998 284 287
4. H.G. Davies, R.J. Richter, M. Keifer, C.A. Broomfield, J. Sowalla, and C.E. Furlong The effect of human serum paraoxonase polymorphisms is reversed with diazoxon, soman and sarin Nat. Genet. 14 1996 334 336
5. R.D. Harley, S. Billecke, and B.N. La Du Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans Toxicol. Appl. Pharmacol. 157 1999 233 239
6. J. Cowan, L.M. Sinton, A.W. Varley, F.H. Wians, R.W. Haley, and R.S. Munford Gene therapy to prevent organophosphate intoxication Toxicol. Appl. Pharmacol. 173 2001 1 6
7. F. Liu, Y. Song, and D. Liu Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 6 1999 1258 1266
8. H. Maruyama, N. Higuchi, Y. Nishikawa, S. Kameda, N. Iino, J.J. Kazama, N. Takahashi, M. Sugawa, H. Hanawa, N. Tada, J. Miyazaki, and F. Gejyo High-level expression of naked DNA delivery to rat liver via tail vein injection J. Gene Med. 4 2002 333 341
9. K.N. Gan, A. Smolen, H.W. Eckerson, and B.N. La Du Purification of human serum paraoxonase/arylesterase Drug Metab. Dispos. 19 1991 100 106
10. C.E. Furlong, R.J. Richter, S.L. Seidel, and A.G. Motulsky Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chorpyrifos-oxon and paraoxon Am. J. Hum. Genet. 43 1988 230 238
11. Q.D. Wang, M.J. Sun, P.T. Huang, and C.F. Huang Micro-colorimetric determication and properties of soman-hydrolyzing enzyme in human liver Chin. J. Pharmacol.Toxicol. 9 1995 245 249
12. C. Magin-Lachmann, G. Kotzamanis, L. D'Aiuto, H. Cooke, C. Huxley, and E. Wagner In vitro and in vivo delivery of intact BAC DNA-comparison of different methods J. Gene Med. 6 2004 195 209
13. H. Herweijer, and J.A. Wolff Progress and prospects: naked DNA gene transfer and therapy Gene Ther. 10 2003 453 458
14. J. Newmark Therapy for nerve agent poisoning Arch. Neurol. 61 2004 649 652